Inventiva SA (IVA)
1.84
+0.05
(+2.79%)
USD |
NASDAQ |
Sep 27, 16:00
1.78
-0.06
(-3.26%)
After-Hours: 20:00
Inventiva Research and Development Expense (Annual): 119.10M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 119.10M |
| December 31, 2022 | 63.77M |
| December 31, 2021 | 57.33M |
| December 31, 2020 | 27.09M |
| December 31, 2019 | 37.83M |
| December 31, 2018 | 37.50M |
| Date | Value |
|---|---|
| December 31, 2017 | 30.28M |
| December 31, 2016 | 24.51M |
| December 31, 2015 | 21.79M |
| December 31, 2014 | 21.65M |
| December 31, 2013 | 18.26M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
27.09M
Minimum
2020
119.10M
Maximum
2023
61.02M
Average
57.33M
Median
2021
Research and Development Expense (Annual) Benchmarks
| DBV Technologies SA | 60.22M |
| Cellectis SA | 87.65M |
| Genfit SA | 50.57M |
| Innate Pharma SA | 60.65M |
| Nanobiotix SA | 41.57M |